NCT04652778View on ClinicalTrials.gov

Safety & Performance of the Centauri System for Patients With Atrial Fibrillation

NAUnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2023

Conditions
Atrial Fibrillation
Interventions
DEVICE

Pulsed Field Ablation (PFA) using the Centauri System

cardiac ablation using pulsed electric field energy to cause pulmonary vein isolation; cavo-tricuspid isthmus (CTI) line ablation may be performed as needed

Trial Locations (1)

L3Y 2P9

Southlake Regional Health Centre, Newmarket

Sponsors
All Listed Sponsors
lead

Galaxy Medical, Inc.

INDUSTRY